ArticleMolecular medicine (Cambridge, Mass.)2026

CD4 T-cell platform for delivering interferons as an antiviral countermeasure with a focus on SARS-CoV-2.

Xiaohe Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.